查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
流式细胞术市场规模、份额和趋势分析报告：按产品（仪器、软件）、技术（基于珠子、基于细胞）、应用（工业、临床）、最终用途、细分市场预测，2022- 2030年
市场调查报告书
商品编码
1171056

流式细胞术市场规模、份额和趋势分析报告：按产品（仪器、软件）、技术（基于珠子、基于细胞）、应用（工业、临床）、最终用途、细分市场预测，2022- 2030年

Flow Cytometry Market Size, Share & Trends Analysis Report By Product (Instruments, Software), By Technology (Bead-based, Cell-based), By Application (Industrial, Clinical), By End-use, And Segment Forecasts, 2022 - 2030
出版日期: | 出版商: Grand View Research | 英文 166 Pages | 商品交期: 2-10个工作天内

价格

流式细胞术市场增长和趋势

根据 Grand View Research, Inc. 的一份新报告，到 2030 年，全球流式细胞术市场规模预计将达到 92.8 亿美元，预测期内的复合年增长率为 7.07%。这项技术的进步正在引入新的和改进的分析工具，例如用于即时 (PoC) 测试的微流体流式细胞仪的开发。此外，癌症、免疫缺陷病和传染病的患病率上升正在推动该行业的发展。此外，生物製药、生命科学和生物技术研究活动的研发投资不断增加，导致对流式细胞术仪器的需求增加。近年来，用于PoC检测的便携式微流控流式细胞仪的开发成为一个重要的焦点。

微流体和流式细胞术的结合为测量生物样品的多种特性提供了有用的工具。例如，多种微流体和小型化检测器的现成可用性使得基于微芯片的细胞仪的发展成为可能，包括光流控细胞仪、成像细胞仪和阻抗细胞仪。微流体流式细胞术设备的发展是有益的，因为它们具有成本效益、便携和紧凑。此外，荧光染料的改进和台式细胞仪在学术研究环境中的实用性增加有望推动该行业的发展。

多色流式细胞术的发展正在加速该技术在药物开发活动中的采用。例如，2020年1月，Beckman Coulter Life Sciences在欧洲推出了13色临床流式细胞仪DxFLEX、CE-IVD。同样，通过同时评估多个参数进行细胞分析的便利性使得此类仪器可广泛用于合同研究目的。COVID-19 大流行也刺激了技术创新，这一领域的新产品发布就是证明。例如，2021 年 7 月，Metropolis Healthcare, Inc. 推出了 CoviRisk-TBNK，这是一种简单的血液检测，用于检测住院 COVID-19 患者的风险状态。

分析患者 ICU 设备和通风需求，以帮助减轻医疗资源压力。该测试是一种基于流式细胞术的淋巴细胞亚群测定，已获准用于体外诊断。此外，流式细胞术是免疫细胞计数和表征的重要工具，可用于识别和验证潜在的遗传缺陷。该技术还用于观察和监测干细胞移植后患者的免疫反应，因此器官移植在推动该行业的增长方面发挥着关键作用。据世界卫生组织称，全世界每年进行约 50,000 例干细胞移植，预计这一数字在不久的将来还会增加，从而扩大该技术的应用范围。

另一方面，技术先进的流式细胞术设备在一些新兴国家可能负担不起，因为设备非常昂贵。这些设备的成本可能高达 100,000 美元，这对中小型医院和临床实验室来说是一个重大的预算限制。但像索尼这样的製造商正在推出带有软件的新设备，可以自动执行许多流程。这样的发展不仅会提高技术的可用性，而且有助于在不久的将来降低设备的平均成本（低于 100,000 美元）。

流式细胞仪市场报告亮点

到 2021 年，由于技术进步和慢性病的增加，设备产品部分将占据最大份额。

基于细胞的流式细胞术技术在 2021 年主导行业，原因是对早期诊断的高需求以及对基于细胞的检测的相关益处的日益认识

按应用划分，由于流感、HIV 和 COVID-19 等传染病的研发活动增加，临床部门在 2021 年的销售额中所占份额最大。

由于学术机构和实验室的研发活动增加，学术最终用户部分在 2021 年引领市场

由于科学先进的流式细胞术解决方案的高采用率、高医疗保健支出和完善的医疗保健基础设施，北美将在 2021 年成为市场领先的地区。

由于中国和印度等新兴国家的製药和生物技术行业的增长，亚太地区预计将在 2022 年至 2030 年实现最快的复合年增长率。

目录

第一章 调查方法和范围

  • 调查方法
  • 调查假设
  • 信息采购
    • 购买的数据库
    • GVR内部数据库
    • 次要信息
    • 初步调查
    • 初步调查详情
  • 信息或数据分析
    • 数据分析模型
  • 市场製定和验证
  • 型号详情
    • 商品流向分析（模型一）
      • 方法一：商品流动方法
    • 量价分析（模型二）
      • 方法二：量价分析
  • 二级信息列表
  • 目的
    • 流式细胞术市场的市场预测

第二章执行摘要

  • 市场快照
  • 段快照
  • 竞争格局的快照

3. 流式细胞术市场变量、趋势和范围

  • 市场系列展望
    • 母公司市场展望
    • 相关/子公司市场展望
  • 绘製渗透率和增长前景
    • 产品优先的关键机会
    • 技术优先的关键机会
    • 应用优先的关键机会
    • 最终用途优先考虑的关键机会
  • 市场动态
    • 市场驱动力分析
      • 慢性病和传染病的流行
      • 对生物技术、临床和生命科学研究的重大研发投资
      • 流式细胞术仪器和试剂的技术进步
      • 对即时诊断的需求不断增长
    • 市场约束因素分析
      • 设备成本高
    • 市场挑战
      • 低细胞吞吐率
  • 流式细胞术：一种市场分析工具
    • 行业分析 - 搬运工
    • 流式细胞术 - SWOT 分析，按因素（政治和法律，经济和技术）
  • 监管和报销场景
  • 价格分析
  • 交易数据
    • 流式细胞仪进出口国数据
  • COVID-19 影响分析

第四章产品经营分析

  • 流式细胞术市场：产品变化分析，2021 年和 2030 年
  • 乐器
    • 细胞分析仪
    • 细胞分选仪
  • 试剂和耗材
  • 软件
  • 配件
  • 服务

第五章技术业务分析

  • 流式细胞术市场：技术波动分析，2021 年和 2030 年
  • 细胞基础
  • 珠座

第六章应用业务分析

  • 流式细胞术市场：应用变化分析，2021 年和 2030 年
  • 研究
    • 药品
      • 药物发现
      • 体外毒性
      • 干细胞
    • 凋亡
    • 细胞分选
    • 细胞週期分析
    • 免疫学
    • 细胞活力
  • 行业
  • 临床
    • 癌症
    • 器官移植
    • 免疫缺陷
    • 血液学

第 7 章终端使用业务分析

  • 流式细胞术市场：最终用途变化分析，2021 年和 2030 年
  • 商业机构
    • 生物技术公司
    • 製药公司
    • 叉
  • 医院
  • 学术机构
  • 临床实验室

第八章区域业务分析

  • 流式细胞仪市场：区域差异分析
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 俄罗斯
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳大利亚
    • 新加坡
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙特阿拉伯
    • 阿拉伯联合酋长国

第九章流式细胞仪市场竞争格局

  • 主要市场进入者的最新发展和影响分析
  • 公司分类
  • 供应商情况
    • 主要经销商及渠道合作伙伴名单
  • 上市公司
    • 公司市场分析
    • 2021 年全球主要参与者市场份额分析
  • 民营企业
    • 主要初创企业名单
    • 公司市场分析
  • Regional Network Map
  • 公司简介
    • DANAHER CORPORATION
      • 公司简介
      • BioTek Instruments, Inc.
      • 公司简介
      • Citiba
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • BECTON, DICKINSON AND COMPANY（BD）
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • SYSMEX CORPORATION
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • AGILENT TECHNOLOGIES, INC.
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • APOGEE FLOW SYSTEMS LTD.
      • 公司简介
      • 产品基准
      • 战略举措
    • BIO-RAD LABORATORIES, INC.
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • THERMO FISHER SCIENTIFIC, INC.
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • STRATEDIGM, INC.
      • 公司简介
      • 产品基准
      • 战略举措
    • DIASORIN SPA
      • 公司简介
      • Luminex Co., Ltd.
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • MILTENYI BIOTEC
      • 公司简介
      • 产品基准
      • 战略举措
    • SONY BIOTECHNOLOGY, INC.
      • 公司简介
      • 产品基准
      • 战略举措
Product Code: GVR-1-68038-412-3

Flow Cytometry Market Growth & Trends:

The global flow cytometry market size is expected to reach USD 9.28 billion by 2030, registering a CAGR of 7.07% over the forecast period, according to a new report by Grand View Research, Inc. Technological advancements in the technique are introducing new and improved analytical tools, which include the development of microfluidic flow cytometry for Point-of-Care (PoC) testing. Furthermore, the rising prevalence of cancer, immunodeficiency disorders, and infectious diseases is driving the industry. In addition, increasing R&D investments in biopharmaceutical, life science, and biotechnology research activities have led to high demand for flow cytometry instruments.In recent years, a key focus has been on the development of portable microfluidic flow cytometry devices for PoC testing.

Microfluidics and flow cytometry together make a useful tool to measure multiple characteristics of biological samples. For instance, the easy availability of several microfluidics and miniaturized detectors have enabled the creation of microchip-based cytometers, such as optofluidic cytometer, imaging cytometer, and impedance cytometer. The development of microfluidic flow cytometry devices, which are cost-effective, portable, and compact, is beneficial. They are affordable in developing economies, such as Asia & Africa, and are enabling rapid growth in PoC testing applications.Furthermore, improvements in fluorescent dyes and the increasing utility of benchtop cytometers for academic research settings are expected to drive the industry.

Developments in multicolor flow cytometry are accelerating the adoption of the technique in novel drug development activities. For instance, in January 2020, DxFLEX, CE-IVD, a 13-colour clinical flow cytometry system was launched by Beckman Coulter Life Sciences in Europe. Similarly, easy cellular analysis by simultaneous evaluation of several parameters allows extensive use of such devices for contract research purposes.The COVID-19 pandemic also spurred innovations in the technique, as evidenced by the launch of new products in this domain. For instance, in July 2021, Metropolis Healthcare Ltd. launched CoviRisk-TBNK, a simple blood test to detect the risk status of a COVID-19 hospitalized patient.

It helps analyze patients' need for ICU facilities or ventilation and aids in the reduction of stress on healthcare resources. The test is a flow cytometry-based lymphocyte subset assay and is IVD-approved. Such innovations are anticipated to fuel industry growth in the near future.Moreover, flow cytometry is a significant tool in listing and characterizing immune cells, and is also helpful in recognizing and validating underlying genetic defects. The technique is also used to observe and monitor the immune response of patients after stem cell transplantation, and hence, organ transplantation plays an important role in boosting industry growth. According to the WHO, around 50,000 stem cell transplantations are performed globally every year, and this number is expected to grow in the near future, broadening the scope of applications for the technique.

On the other hand, instruments are highly expensive, and hence, buyers in several developing countries may not be able to afford technologically advanced flow cytometry equipment. These instruments may cost over USD 100,000 and pose significant budgetary constraints for small- & mid-sized hospitals and clinical laboratories. However, some manufacturers, such as Sony, are trying to launch newer instruments using software to automate a number of processes. Such developments would not only improve the usability of the technique but also help bring down the average instrumentation cost-under USD 100,000-in the near future.

Flow Cytometry Market Report Highlights:

  • The instrument product segment held the largest share in 2021 due to technical advancements, as well as increased prevalence of chronic conditions
  • Thecell-based flow cytometry technology dominated the industry in 2021 due to the high demand for early diagnosis and rising awareness about the associated benefits of cell-based assays
  • By application, the clinical segment accounted for the largest revenue share in 2021 owing to increasedR&D activities pertaining to infectious diseases, such as influenza, HIV, and COVID-19, among others
  • The academic institutes end-user segment led the market in 2021 owing to increased R&D activities by academic institutes & research centers
  • North America was theleadingregion in 2021due to the high implementation of scientifically advanced flow cytometry solutions, high healthcare expenditure, and well-established healthcare infrastructure in the region
  • Asia Pacific is expected to register the fastest CAGR from 2022 to 2030 owing to the extensive growth in the pharmaceutical and biotechnology industries in emerging economies, such as China and India

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Research Methodology
  • 1.2 Research Assumptions
    • 1.2.1 Estimates And Forecast Timeline
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 Gvr's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details Of Primary Research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis (Model 1)
      • 1.6.1.1 Approach 1: Commodity Flow Approach
    • 1.6.2 Volume Price Analysis (Model 2)
      • 1.6.2.1 Approach 2: Volume Price Analysis
  • 1.7 List Of Secondary Sources
  • 1.8 Objectives
    • 1.8.1 Objective 1:
    • 1.8.2 Objective 2:
    • 1.8.3 Market Estimation For Flow Cytometry Market

Chapter 2 Executive Summary

  • 2.1 Market Snapshot
  • 2.2 Segment Snapshot
  • 2.3 Competitive Landscape Snapshot

Chapter 3 Flow Cytometry Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Outlook
    • 3.1.2 Related/Ancillary Market Outlook
  • 3.2 Penetration & Growth Prospect Mapping
    • 3.2.1 Key Opportunities Prioritized, By Product
    • 3.2.2 Key Opportunities Prioritized, By Technology
    • 3.2.3 Key Opportunities Prioritized, By Application
    • 3.2.4 Key Opportunities Prioritized, By End Use
  • 3.3 Market Dynamics
    • 3.3.1 Market Driver Analysis
      • 3.3.1.1 Growing Prevalence Of Chronic And Infectious Diseases
      • 3.3.1.2 High R&D Investments In Biotechnology, Clinical, And Life Science Research
      • 3.3.1.3 Technological Advancements In Flow Cytometry Instruments And Reagents
      • 3.3.1.4 Increasing Demand For Point-Of-Care Diagnostics
    • 3.3.2 Market Restraint Analysis
      • 3.3.2.1 High Cost Of Instruments
    • 3.3.3 Market Challenges
      • 3.3.3.1 Low Cell Throughput Rate
  • 3.4 Flow Cytometry: Market Analysis Tools
    • 3.4.1 Industry Analysis - Porter's
    • 3.4.2 Flow Cytometry - Swot Analysis, By Factor (Political & Legal, Economic And Technological)
  • 3.5 Regulatory & Reimbursement Scenario
  • 3.6 Pricing Analysis
  • 3.7 Trade Data
    • 3.7.1 Import/Export Data For Flow Cytometers, By Country
  • 3.8 Covid-19 Impact Analysis

Chapter 4 Product Business Analysis

  • 4.1 Flow Cytometry Market: Product Movement Analysis, 2021 & 2030
  • 4.2 Instruments
    • 4.2.1 Global Instruments Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 4.2.2 Cell Analyzers
      • 4.2.2.1 Global Cell Analyzers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 4.2.3 Cell Sorters
      • 4.2.3.1 Global Cell Sorters Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 4.3 Reagents & Consumables
    • 4.3.1 Global Reagents & Consumables Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 4.4 Software
    • 4.4.1 Global Software Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 4.5 Accessories
    • 4.5.1 Global Accessories Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 4.6 Services
    • 4.6.1 Global Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 5 Technology Business Analysis

  • 5.1 Flow Cytometry Market: Technology Movement Analysis, 2021 & 2030
  • 5.2 Cell-Based
    • 5.2.1 Global Cell-Based Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.3 Bead-Based
    • 5.3.1 Global Bead-Based Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 6 Application Business Analysis

  • 6.1 Flow Cytometry Market: Application Movement Analysis, 2021 & 2030
  • 6.2 Research
    • 6.2.1 Global Research Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2 Pharmaceutical
      • 6.2.2.1 Global Pharmaceutical Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 6.2.2.2 Drug Discovery
      • 6.2.2.2.1 Global Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 6.2.2.3 In Vitro Toxicity
      • 6.2.2.3.1 Global In Vitro Toxicity Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 6.2.2.4 Stem Cell
      • 6.2.2.4.1 Global Stem Cell Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.3 Apoptosis
      • 6.2.3.1 Global Apoptosis Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.4 Cell Sorting
      • 6.2.4.1 Global Cell Sorting Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.5 Cell Cycle Analysis
      • 6.2.5.1 Global Cell Cycle Analysis Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.6 Immunology
      • 6.2.6.1 Global Immunology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.7 Cell Viability
      • 6.2.7.1 Global Cell Viability Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.3 Industrial
    • 6.3.1 Global Industrial Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.4 Clinical
    • 6.4.1 Global Clinical Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2 Cancer
      • 6.4.2.1 Global Cancer Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3 Organ Transplantation
      • 6.4.3.1 Global Organ Transplantation Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4 Immunodeficiency
      • 6.4.4.1 Global Immunodeficiency Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.4.5 Hematology
      • 6.4.5.1 Global Hematology Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 7 End Use Business Analysis

  • 7.1 Flow Cytometry Market: End-Use Movement Analysis, 2021 & 2030
  • 7.2 Commercial Organizations
    • 7.2.1 Global Commercial Organizations Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.2.2 Biotechnology Companies
      • 7.2.2.1 Global Biotechnology Companies Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.2.3 Pharmaceutical Companies
      • 7.2.3.1 Global Pharmaceutical Companies Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.2.4 CROS
      • 7.2.4.1 Global CROS Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.3 Hospitals
    • 7.3.1 Global Hospitals Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.4 Academic Institutes
    • 7.4.1 Global Academic Institutes Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5 Clinical Testing Labs
    • 7.5.1 Global Clinical Testing Labs Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8 Regional Business Analysis

  • 8.1 Flow Cytometry Market: Regional Movement Analysis
  • 8.2 North America
    • 8.2.1 North America Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.2.2 U.S.
      • 8.2.2.1 U.S. Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.2.3 Canada
      • 8.2.3.1 Canada Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.3 Europe
    • 8.3.1 Europe Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.3.2 Germany
      • 8.3.2.1 Germany Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.3.3 U.K.
      • 8.3.3.1 U.K. Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.3.4 France
      • 8.3.4.1 France Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.3.5 Italy
      • 8.3.5.1 Italy Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.3.6 Spain
      • 8.3.6.1 Spain Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.3.7 Russia
      • 8.3.7.1 Russia Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.4 Asia Pacific
    • 8.4.1 Asia Pacific Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.4.2 Japan
      • 8.4.2.1 Japan Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.4.3 China
      • 8.4.3.1 China Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.4.4 India
      • 8.4.4.1 India Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.4.5 South Korea
      • 8.4.5.1 South Korea Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.4.6 Australia
      • 8.4.6.1 Australia Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.4.7 Singapore
      • 8.4.7.1 Singapore Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.5 Latin America
    • 8.5.1 Latin America Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.5.2 Brazil
      • 8.5.2.1 Brazil Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.5.3 Mexico
      • 8.5.3.1 Mexico Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.5.4 Argentina
      • 8.5.4.1 Argentina Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.6 Middle East & Africa
    • 8.6.1 Middle East & Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.6.2 South Africa
      • 8.6.2.1 South Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.6.3 Saudi Arabia
      • 8.6.3.1 Saudi Arabia Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.6.4 UAE
      • 8.6.4.1 UAE Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 9 Flow Cytometry Market Competitive Landscape

  • 9.1 Recent Developments & Impact Analysis, By Key Market Participants
  • 9.2 Company Categorization
  • 9.3 Vendor Landscape
    • 9.3.1 List Of Key Distributors And Channel Partners
  • 9.4 Public Companies
    • 9.4.1 Company Market Position Analysis
    • 9.4.2 Global Key Company Market Share Analysis, 2021
  • 9.5 Private Companies
    • 9.5.1 List Of Key Emerging Companies
    • 9.5.2 Company Market Position Analysis
  • 9.6 Regional Network Map
  • 9.7 Company Profiles
    • 9.7.1 DANAHER CORPORATION
      • 9.7.1.1 Company overview
      • 9.7.1.2 Beckman Coulter, Inc.
      • 9.7.1.2.1 COMPANY OVERVIEW
      • 9.7.1.3 Cytiva
      • 9.7.1.3.1 COMPANY OVERVIEW
      • 9.7.1.4 Financial performance
      • 9.7.1.5 Product benchmarking
      • 9.7.1.6 Strategic initiatives
    • 9.7.2 BECTON, DICKINSON AND COMPANY (BD)
      • 9.7.2.1 Company overview
      • 9.7.2.2 Financial performance
      • 9.7.2.3 Product benchmarking
      • 9.7.2.4 Strategic initiatives
    • 9.7.3 SYSMEX CORPORATION
      • 9.7.3.1 Company overview
      • 9.7.3.2 Financial performance
      • 9.7.3.3 Product benchmarking
      • 9.7.3.4 Strategic initiatives
    • 9.7.4 AGILENT TECHNOLOGIES, INC.
      • 9.7.4.1 Company overview
      • 9.7.4.2 Financial performance
      • 9.7.4.3 Product benchmarking
      • 9.7.4.4 Strategic initiatives
    • 9.7.5 APOGEE FLOW SYSTEMS LTD.
      • 9.7.5.1 Company overview
      • 9.7.5.2 Product benchmarking
      • 9.7.5.3 Strategic initiatives
    • 9.7.6 BIO-RAD LABORATORIES, INC.
      • 9.7.6.1 Company overview
      • 9.7.6.2 Financial performance
      • 9.7.6.3 Product benchmarking
      • 9.7.6.4 Strategic initiatives
    • 9.7.7 THERMO FISHER SCIENTIFIC, INC.
      • 9.7.7.1 Company overview
      • 9.7.7.2 Financial performance
      • 9.7.7.3 Product benchmarking
      • 9.7.7.4 Strategic initiatives
    • 9.7.8 STRATEDIGM, INC.
      • 9.7.8.1 Company overview
      • 9.7.8.2 Product benchmarking
      • 9.7.8.3 Strategic initiatives
    • 9.7.9 DIASORIN S.P.A.
      • 9.7.9.1 Company overview
      • 9.7.9.2 Luminex Corporation
      • 9.7.9.2.1 COMPANY OVERVIEW
      • 9.7.9.3 Financial performance
      • 9.7.9.4 Product benchmarking
      • 9.7.9.5 Strategic initiatives
    • 9.7.10 MILTENYI BIOTEC
      • 9.7.10.1 Company overview
      • 9.7.10.2 Product benchmarking
      • 9.7.10.3 Strategic initiatives
    • 9.7.11 SONY BIOTECHNOLOGY, INC.
      • 9.7.11.1 Company overview
      • 9.7.11.2 Product benchmarking
      • 9.7.11.3 Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 Regulatory status and recommended validation strategy for flow cytometry assays
  • Table 3 CPT codes for flow cytometry reimbursement
  • Table 4 Global flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 5 Global flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 6 Global flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 7 Global flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 8 Global flow cytometry market, by region, 2018 - 2030 (USD Million)
  • Table 9 North America flow cytometry market, by country, 2018 - 2030 (USD Million)
  • Table 10 North America flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 11 North America flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 12 North America flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 13 North America flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 14 U.S. Flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 15 U.S. Flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 16 U.S. Flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 17 U.S. Flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 18 Canada flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 19 Canada flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 20 Canada flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 21 Canada flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 22 Europe flow cytometry market, by country, 2018 - 2030 (USD Million)
  • Table 23 Europe flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 24 Europe flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 25 Europe flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 26 Europe flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 27 Germany flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 28 Germany flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 29 Germany flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 30 Germany flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 31 U.K. flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 32 U.K. flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 33 U.K. flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 34 U.K. flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 35 France flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 36 France flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 37 France flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 38 France flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 39 Italy flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 40 Italy flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 41 Italy flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 42 Italy flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 43 Spain flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 44 Spain flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 45 Spain flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 46 Spain flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 47 Russia flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 48 Russia flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 49 Russia flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 50 Russia flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 51 Asia pacific flow cytometry market, by country, 2018 - 2030 (USD Million)
  • Table 52 Asia pacific flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 53 Asia pacific flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 54 Asia pacific flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 55 Asia pacific flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 56 China flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 57 China flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 58 China flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 59 China flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 60 India flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 61 India flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 62 India flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 63 India flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 64 Japan flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 65 Japan flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 66 Japan flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 67 Japan flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 68 South Korea flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 69 South Korea flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 70 South Korea flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 71 South Korea flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 72 Australia flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 73 Australia flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 74 Australia flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 75 Australia flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 76 Singapore flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 77 Singapore flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 78 Singapore flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 79 Singapore flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 80 Latin America flow cytometry market, by country, 2018 - 2030 (USD Million)
  • Table 81 Latin America flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 82 Latin America flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 83 Latin America flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 84 Latin America flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 85 Brazil flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 86 Brazil flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 87 Brazil flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 88 Brazil flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 89 Mexico flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 90 Mexico flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 91 Mexico flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 92 Mexico flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 93 Argentina flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 94 Argentina flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 95 Argentina flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 96 Argentina flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 97 Middle east & Africa flow cytometry market, by country, 2018 - 2030 (USD Million)
  • Table 98 Middle east & Africa flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 99 Middle east & Africa flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 100 Middle east & Africa flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 101 Middle east & Africa flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 102 South Africa flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 103 South Africa flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 104 South Africa flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 105 South Africa flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 106 Saudi Arabia flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 107 Saudi Arabia flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 108 Saudi Arabia flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 109 Saudi Arabia flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 110 UAE flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 111 UAE flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 112 UAE flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 113 UAE flow cytometry market, end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Commodity flow analysis
  • Fig. 10 Volume price analysis
  • Fig. 11 Market snapshot
  • Fig. 12 Segment snapshot
  • Fig. 13 Competitive landscape snapshot
  • Fig. 14 Parent market outlook (2021)
  • Fig. 15 Penetration & growth prospect mapping, by product
  • Fig. 16 Penetration & growth prospect mapping, by technology
  • Fig. 17 Penetration & growth prospect mapping, by application
  • Fig. 18 Penetration & growth prospect mapping, by end use
  • Fig. 19 Flow cytometry market driver impact
  • Fig. 20 Flow cytometry market restraint impact
  • Fig. 21 Porter's five force analysis
  • Fig. 22 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 23 Flow cytometers import shipments data (2022)
  • Fig. 24 Flow cytometers export shipments data (2022)
  • Fig. 25 Flow cytometry market: product outlook & key takeaways
  • Fig. 26 Flow cytometry market: product movement analysis
  • Fig. 27 Global instruments market, 2018 - 2030 (USD Million)
  • Fig. 28 Global cell analyzers market, 2018 - 2030 (USD Million)
  • Fig. 29 Global cell sorters market, 2018 - 2030 (USD Million)
  • Fig. 30 Global reagents & consumables market, 2018 - 2030 (USD Million)
  • Fig. 31 Global software market, 2018 - 2030 (USD Million)
  • Fig. 32 Global accessories market, 2018 - 2030 (USD Million)
  • Fig. 33 Global services market, 2018 - 2030 (USD Million)
  • Fig. 34 Flow cytometry market: technology outlook & key takeaways
  • Fig. 35 Flow cytometry market: technology movement analysis
  • Fig. 36 Global cell-based market, 2018 - 2030 (USD Million)
  • Fig. 37 Global bead-based market, 2018 - 2030 (USD Million)
  • Fig. 38 Flow cytometry market: application outlook & key takeaways
  • Fig. 39 Flow cytometry market: application movement analysis
  • Fig. 40 Global research application market, 2018 - 2030 (USD Million)
  • Fig. 41 Global pharmaceutical application market, 2018 - 2030 (USD Million)
  • Fig. 42 Global drug discovery application market, 2018 - 2030 (USD Million)
  • Fig. 43 Global in vitro toxicity application market, 2018 - 2030 (USD Million)
  • Fig. 44 Global stem cell application market, 2018 - 2030 (USD Million)
  • Fig. 45 Global apoptosis application market, 2018 - 2030 (USD Million)
  • Fig. 46 Global cell sorting application market, 2018 - 2030 (USD Million)
  • Fig. 47 Global cell cycle analysis application market, 2018 - 2030 (USD Million)
  • Fig. 48 Global immunology application market, 2018 - 2030 (USD Million)
  • Fig. 49 Global cell viability application market, 2018 - 2030 (USD Million)
  • Fig. 50 Global industrial application market, 2018 - 2030 (USD Million)
  • Fig. 51 Global clinical application market, 2018 - 2030 (USD Million)
  • Fig. 52 Global cancer application market, 2018 - 2030 (USD Million)
  • Fig. 53 Global organ transplantation application market, 2018 - 2030 (USD Million)
  • Fig. 54 Global immunodeficiency application market, 2018 - 2030 (USD Million)
  • Fig. 55 Global hematology application market, 2018 - 2030 (USD Million)
  • Fig. 56 Flow cytometry market: end use outlook & key takeaways
  • Fig. 57 Flow cytometry market: end use movement analysis
  • Fig. 58 Global commercial organizations market, 2018 - 2030 (USD Million)
  • Fig. 59 Global biotechnology companies market, 2018 - 2030 (USD Million)
  • Fig. 60 Global pharmaceutical companies market, 2018 - 2030 (USD Million)
  • Fig. 61 Global CROs market, 2018 - 2030 (USD Million)
  • Fig. 62 Global hospitals market, 2018 - 2030 (USD Million)
  • Fig. 63 Global academic institutes market, 2018 - 2030 (USD Million)
  • Fig. 64 Global clinical testing labs market, 2018 - 2030 (USD Million)
  • Fig. 65 Regional marketplace: key takeaway
  • Fig. 66 Flow cytometry market: regional movement analysis
  • Fig. 67 North America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 68 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 69 Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 70 Europe market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 71 Germany market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 72 U.K. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 73 France market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 74 Italy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 75 Spain market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 76 Russia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 77 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 78 Japan market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 79 China market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 80 India market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 81 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 82 Australia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 83 Singapore market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 84 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 85 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 86 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 87 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 88 Middle East and Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 89 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 90 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 91 UAE market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 92 Heat map analysis, by key market participants
  • Fig. 93 Participant categorization - flow cytometry market
  • Fig. 94 Public company market position analysis, 2021
  • Fig. 95 Global key company market share analysis, 2021
  • Fig. 96 Private company market position analysis, 2021
  • Fig. 97 Regional network map